Literature DB >> 33163005

The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.

Chanan Meydan1,2,3, Nimrod Madrer4, Hermona Soreq4.   

Abstract

The COVID-19 pandemic exerts inflammation-related parasympathetic complications and post-infection manifestations with major inter-individual variability. To seek the corresponding transcriptomic origins for the impact of COVID-19 infection and its aftermath consequences, we sought the relevance of long and short non-coding RNAs (ncRNAs) for susceptibility to COVID-19 infection. We selected inflammation-prone men and women of diverse ages among the cohort of Genome Tissue expression (GTEx) by mining RNA-seq datasets from their lung, and blood tissues, followed by quantitative qRT-PCR, bioinformatics-based network analyses and thorough statistics compared to brain cell culture and infection tests with COVID-19 and H1N1 viruses. In lung tissues from 57 inflammation-prone, but not other GTEx donors, we discovered sharp declines of the lung pathology-associated ncRNA DANCR and the nuclear paraspeckles forming neuroprotective ncRNA NEAT1. Accompanying increases in the acetylcholine-regulating transcripts capable of controlling inflammation co-appeared in SARS-CoV-2 infected but not H1N1 influenza infected lung cells. The lung cells-characteristic DANCR and NEAT1 association with inflammation-controlling transcripts could not be observed in blood cells, weakened with age and presented sex-dependent links in GTEx lung RNA-seq dataset. Supporting active involvement in the inflammatory risks accompanying COVID-19, DANCR's decline associated with decrease of the COVID-19-related cellular transcript ACE2 and with sex-related increases in coding transcripts potentiating acetylcholine signaling. Furthermore, transcription factors (TFs) in lung, brain and cultured infected cells created networks with the candidate transcripts, indicating tissue-specific expression patterns. Supporting links of post-infection inflammatory and cognitive damages with cholinergic mal-functioning, man and woman-originated cultured cholinergic neurons presented differentiation-related increases of DANCR and NEAT1 targeting microRNAs. Briefly, changes in ncRNAs and TFs from inflammation-prone human lung tissues, SARS-CoV-2-infected lung cells and man and woman-derived differentiated cholinergic neurons reflected the inflammatory pathobiology related to COVID-19. By shifting ncRNA differences into comparative diagnostic and therapeutic profiles, our RNA-sequencing based Resource can identify ncRNA regulating candidates for COVID-19 and its associated immediate and predicted long-term inflammation and neurological complications, and sex-related therapeutics thereof. Our findings encourage diagnostics of involved tissue, and further investigation of NEAT1-inducing statins and anti-cholinergic medications in the COVID-19 context.
Copyright © 2020 Meydan, Madrer and Soreq.

Entities:  

Keywords:  COVID-19; central nervous system; cholinergic; long non-coding RNA; miRNA

Mesh:

Substances:

Year:  2020        PMID: 33163005      PMCID: PMC7581732          DOI: 10.3389/fimmu.2020.590870

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  164 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Pandemic H1N1 influenza A directly induces a robust and acute inflammatory gene signature in primary human bronchial epithelial cells downstream of membrane fusion.

Authors:  Stéphane G Paquette; David Banner; Le Thi Bao Chi; Alberto J Leόn; Luoling Xu; Longsi Ran; Stephen S H Huang; Amber Farooqui; David J Kelvin; Alyson A Kelvin
Journal:  Virology       Date:  2013-10-22       Impact factor: 3.616

3.  MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease.

Authors:  Nitsan Maharshak; Shani Shenhar-Tsarfaty; Nimrod Aroyo; Naama Orpaz; Irene Guberman; Jonathan Canaani; Zamir Halpern; Iris Dotan; Shlomo Berliner; Hermona Soreq
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

4.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

Authors:  Riccardo M Inciardi; Laura Lupi; Gregorio Zaccone; Leonardo Italia; Michela Raffo; Daniela Tomasoni; Dario S Cani; Manuel Cerini; Davide Farina; Emanuele Gavazzi; Roberto Maroldi; Marianna Adamo; Enrico Ammirati; Gianfranco Sinagra; Carlo M Lombardi; Marco Metra
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

Review 5.  Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.

Authors:  W Joost Wiersinga; Andrew Rhodes; Allen C Cheng; Sharon J Peacock; Hallie C Prescott
Journal:  JAMA       Date:  2020-08-25       Impact factor: 56.272

6.  Molecular Regulatory Pathways Link Sepsis With Metabolic Syndrome: Non-coding RNA Elements Underlying the Sepsis/Metabolic Cross-Talk.

Authors:  Chanan Meydan; Uriya Bekenstein; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2018-06-05       Impact factor: 5.639

7.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.

Authors:  Leora R Feldstein; Erica B Rose; Steven M Horwitz; Jennifer P Collins; Margaret M Newhams; Mary Beth F Son; Jane W Newburger; Lawrence C Kleinman; Sabrina M Heidemann; Amarilis A Martin; Aalok R Singh; Simon Li; Keiko M Tarquinio; Preeti Jaggi; Matthew E Oster; Sheemon P Zackai; Jennifer Gillen; Adam J Ratner; Rowan F Walsh; Julie C Fitzgerald; Michael A Keenaghan; Hussam Alharash; Sule Doymaz; Katharine N Clouser; John S Giuliano; Anjali Gupta; Robert M Parker; Aline B Maddux; Vinod Havalad; Stacy Ramsingh; Hulya Bukulmez; Tamara T Bradford; Lincoln S Smith; Mark W Tenforde; Christopher L Carroll; Becky J Riggs; Shira J Gertz; Ariel Daube; Amanda Lansell; Alvaro Coronado Munoz; Charlotte V Hobbs; Kimberly L Marohn; Natasha B Halasa; Manish M Patel; Adrienne G Randolph
Journal:  N Engl J Med       Date:  2020-06-29       Impact factor: 91.245

8.  In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.

Authors:  Xiao-Jing Zhang; Juan-Juan Qin; Xu Cheng; Lijun Shen; Yan-Ci Zhao; Yufeng Yuan; Fang Lei; Ming-Ming Chen; Huilin Yang; Liangjie Bai; Xiaohui Song; Lijin Lin; Meng Xia; Feng Zhou; Jianghua Zhou; Zhi-Gang She; Lihua Zhu; Xinliang Ma; Qingbo Xu; Ping Ye; Guohua Chen; Liming Liu; Weiming Mao; Youqin Yan; Bing Xiao; Zhigang Lu; Gang Peng; Mingyu Liu; Jun Yang; Luyu Yang; Changjiang Zhang; Haofeng Lu; Xigang Xia; Daihong Wang; Xiaofeng Liao; Xiang Wei; Bing-Hong Zhang; Xin Zhang; Juan Yang; Guang-Nian Zhao; Peng Zhang; Peter P Liu; Rohit Loomba; Yan-Xiao Ji; Jiahong Xia; Yibin Wang; Jingjing Cai; Jiao Guo; Hongliang Li
Journal:  Cell Metab       Date:  2020-06-24       Impact factor: 27.287

Review 9.  Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms.

Authors:  Cina Sasannejad; E Wesley Ely; Shouri Lahiri
Journal:  Crit Care       Date:  2019-11-12       Impact factor: 9.097

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  13 in total

1.  Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype.

Authors:  Dinesh Devadoss; Arpan Acharya; Marko Manevski; Dominika Houserova; Michael D Cioffi; Kabita Pandey; Madhavan Nair; Prem Chapagain; Mehdi Mirsaeidi; Glen M Borchert; Siddappa N Byrareddy; Hitendra S Chand
Journal:  iScience       Date:  2022-06-30

2.  The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease.

Authors:  Mohammad Abbasi-Kolli; Javid Sadri Nahand; Seyed Jalal Kiani; Khadijeh Khanaliha; AliReza Khatami; Mohammad Taghizadieh; Ali Rajabi Torkamani; Kimiya Babakhaniyan; Farah Bokharaei-Salim
Journal:  Braz J Infect Dis       Date:  2022-04-25       Impact factor: 3.257

3.  Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129.

Authors:  Lina Badimon; Emma L Robinson; Amela Jusic; Irina Carpusca; Leon J deWindt; Costanza Emanueli; Péter Ferdinandy; Wei Gu; Mariann Gyöngyösi; Matthias Hackl; Kanita Karaduzovic-Hadziabdic; Mitja Lustrek; Fabio Martelli; Eric Nham; Ines Potočnjak; Venkata Satagopam; Reinhard Schneider; Thomas Thum; Yvan Devaux
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

4.  Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis.

Authors:  Kai Huang; Catherine Wang; Christen Vagts; Vanitha Raguveer; Patricia W Finn; David L Perkins
Journal:  PLoS One       Date:  2022-01-10       Impact factor: 3.240

5.  Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.

Authors:  Aliakbar Hasankhani; Abolfazl Bahrami; Negin Sheybani; Behzad Aria; Behzad Hemati; Farhang Fatehi; Hamid Ghaem Maghami Farahani; Ghazaleh Javanmard; Mahsa Rezaee; John P Kastelic; Herman W Barkema
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

6.  Sequence complementarity between human noncoding RNAs and SARS-CoV-2 genes: What are the implications for human health?

Authors:  Rossella Talotta; Shervin Bahrami; Magdalena Janina Laska
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-10-15       Impact factor: 5.187

Review 7.  Cholinergic blockade of neuroinflammation: from tissue to RNA regulators.

Authors:  Tamara Zorbaz; Nimrod Madrer; Hermona Soreq
Journal:  Neuronal Signal       Date:  2022-02-11

Review 8.  (Epi)transcriptomics in cardiovascular and neurological complications of COVID-19.

Authors:  Amela Jusic; Konstantinos Stellos; Lino Ferreira; Andrew H Baker; Yvan Devaux
Journal:  J Mol Cell Cardiol Plus       Date:  2022-07-28

9.  New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer's Disease Research.

Authors:  Przemysław Koźmiński; Dorota Niedziałek; Grzegorz Wieczorek; Paweł K Halik; Kamila Czarnecka; Aleksandra Rogut; Łukasz Cheda; Zbigniew Rogulski; Paweł Szymański; Ewa Gniazdowska
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

10.  Identification of an miRNA Regulatory Network and Candidate Markers for Ischemic Stroke Related to Diabetes.

Authors:  Hui Zhou; Liujia Huang; Lucong Liang; Liechun Chen; Chun Zou; Zhenhua Li; Rongjie Li; Chongdong Jian; Donghua Zou
Journal:  Int J Gen Med       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.